Pharmaceutical

AstraZeneca completes Fusion Pharmaceuticals acquisition

AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.

Jun 6, 2024 - 04:00
AstraZeneca completes Fusion Pharmaceuticals acquisition
AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.
Read the original article

Tags:

Previous Article

J&J seeks expanded approvals for paediatric HIV-1 therapy

Next Article

Climate change may aggravate multiple sclerosis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Intellia propels into 2024 with CRISPR pipeline updates

Intellia propels into 2024 with CRISPR pipeline updates

Jan 5, 2024

PF-07960613 by Pfizer for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval

PF-07960613 by Pfizer for Respiratory Syncytial Virus (...

Jun 14, 2024

STAT+: Study on Amgen’s ‘bispecific’ immunotherapy could lead to approval in small cell lung cancer

STAT+: Study on Amgen’s ‘bispecific’ immunotherapy coul...

Oct 20, 2023